Bruised biotech investors focus on firms with more advanced products

Rather than those at the early stages of development.

Related Keywords

United States ,Lee Brown ,Avery Spear ,Jonathan Norris ,Genocea Biosciences ,Zegbeh Jallah ,Silicon Valley Bank ,Nasdaq ,Reuters ,Renaissance Capital ,Third Bridge ,Nasdaq Biotechnology ,Roth Capital ,